Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 7, 2014SHILAP Revista de lepidopterologíaOpen Access

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis

View Full Paper
Ask AI
Bookmark
Share

Authors

MBMichael BaslerUniversity of KonstanzSMSarah MundtUniversity of ZurichTMTony MuchamuelEnzo Life Sciences (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Basler et al. (2014) studied this question.

synapsesocial.com/papers/69daaa2f84371aa676a3db8chttps://doi.org/10.1002/emmm.201303543
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Distinct 19 S and 20 S subcomplexes of the 26 S proteasome and their distribution in the nucleus and the cytoplasm.1994 · 393 citations
  2. 2CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells2012 · 75 citations
  3. 3Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation2008 · 74 citations
  4. 4Prevention of Experimental Colitis by a Selective Inhibitor of the Immunoproteasome2010 · 237 citations